Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
NPJ Breast Cancer|November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
NPJ Breast Cancer|June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B Daly, Robert Pilarski, Michael Berry, et al.
Cancer Genetics|September 4, 2012
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortiumPhuong L Mai, David Malkin, Judy E Garber, et al.
Cancer Research|July 9, 2009
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriersTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
NPJ Breast Cancer|August 20, 2021
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin AmericaJosef S Herzog, Yanin Chavarri-Guerra, Danielle Castillo, et al.
Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2017
Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline <i>BRCA1</i>- or <i>BRCA2</i>-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083George Somlo, Paul H Frankel, Banu K Arun, et al.
Pageof 22